U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06979635) titled 'Assessing the Safety, Performance, and User Experience of the Tandem Mobi Automated Insulin Delivery System Among Young Competitive Athletes in Real-world Settings.' on May 13.

Brief Summary: A single arm, interventional study with 12 weeks study phase preceded by a 2-week run in phase, aiming to evaluate the effectiveness and applicability of the Tandem Mobi automated insulin delivery system (Tandem Mobi Pump System) for competitive youth athletes with type 1 diabetes in real-world conditions.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Type 1 Diabetes Competitive Athletes Hybrid Closed Loop System

Interv...